CAS 220355-63-5

Fórmula: C32H47N5O5S

InChI: InChI=1S/C32H47N5O5S/c1-8-42-32(39)37-14-12-36(13-15-37)31(38)28(17-23-10-9-11-24(16-23)30(33)34)35-43(40,41)29-26(21(4)5)18-25(20(2)3)19-27(29)22(6)7/h9-11,16,18-22,28,35H,8,12-15,17H2,1-7H3,(H3,33,34)/t28-/m0/s1

Clave InChI: ISJSHQTWOHGCMM-NDEPHWFRSA-N

SMILES: CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC2=CC(=CC=C2)C(=N)N)NS(=O)(=O)C3=C(C=C(C=C3C(C)C)C(C)C)C(C)C

UKI-1

CAS: 220355-63-5

UKI-1

Fórmula: C₃₂H₄₇N₅O₅S

Pureza: 96.03%

Peso molecular: 613.81

Ref: 54-OR1114973

UKI-1

CAS: 220355-63-5

Fórmula: C₃₂H₄₇N₅O₅S

Pureza: 96.03%

Peso molecular: 613.8111

Ref: IN-DA00BF82

Upamostat Impurity 4 Acetate

CAS: 220355-63-5

Fórmula: C₃₂H₄₇N₅O₅S·C₂H₄O₂

Peso molecular: 613.82 60.05

Ref: 4Z-U-112007

Upamostat Impurity 4-d8 Acetate

CAS: 220355-63-5

Fórmula: C₃₂H₃₉D₈N₅O₅S·C₂H₄O₂

Peso molecular: 621.87 60.05

Ref: 4Z-U-112010

UKI-1

CAS: 220355-63-5

UKI-1 is a mutant form of the enzyme urokinase, which is used for the treatment of cancer. It has shown to inhibit metastasis by binding to the extracellular matrix and preventing cells from migrating. UKI-1 has also been found to have a structure that resembles benzamidine, a ligand that can be used as a template for optimisation. The crystal structure of UKI-1 has revealed that it contains an active site with amino acid residues that are similar to those of plasminogen activator (PA) molecules, which are molecules that are involved in blood clotting.

Fórmula: C₃₂H₄₇N₅O₅S

Pureza: Min. 95%

Peso molecular: 613.32979

Ref: 3D-BU178186

UKI-1

CAS: 220355-63-5

UKI-1 is a urokinase-type plasminogen activator system synthetic inhibitor.

Fórmula: C₃₂H₄₇N₅O₅S

Pureza: 98%

Forma y color: Solid

Peso molecular: 613.81

Ref: TM-T13251